Key result
A raised pre-operative INR (≥1.5) was significantly associated with increased thirty-day mortality (60% vs 0%, p=0.001) in patients undergoing simultaneous renal and cardiac surgery.
Why the study?
Does raised preoperative INR predict 30-day mortality in patients undergoing simultaneous cardiac and renal surgery for tumors involving the peri-diaphragmatic inferior vena cava and right atrium?
Cohort (n=41)
No
Does raised preoperative INR predict 30-day mortality in patients undergoing simultaneous cardiac and renal surgery for tumors involving the peri-diaphragmatic inferior vena cava and right atrium?
Effect estimate: OR +∞ (95% CI 4.04 - +∞)
Absolute Event Rate: 60% vs 0%
p-value: p=0.001
Raised preoperative INR (≥1.5) is strongly associated with 30-day mortality and serious complications in patients undergoing simultaneous cardiac and renal surgery for tumors involving the IVC and right atrium.
May warrant preoperative INR assessment before combined surgery; leaves open whether correction improves survival.
Objective To identify preoperative factors that predict 30‐day mortality in patients undergoing simultaneous cardiac and renal surgery for urological tumours involving the peri‐diaphragmatic vena cava and right atrium‐ The ability to predict mortality and therefore avoid surgery in those patients likely to die would be valuable. Patients and Methods We retrospectively reviewed perioperative outcomes in patients managed between December 2007 and January 2016 by a single team. The relationships of outcome measurements were analysed using Fisher's exact and Mann–Whitney U ‐tests. Results Of the 46 patients identified, 41 (89%) underwent surgery (20 males and 21 females). The median (range) age was 65 (17–95) years. Histology confirmed 37 renal cell cancers, one adrenal cancer, two primitive neuroectodermal tumours, and one leiomyosarcoma. The overall 30‐day mortality rate was 7% (three of 41 patients). The international normalised ratio ( INR ), age, and estimated glomerular filtration rate ( eGFR ) correlated significantly with 30‐day mortality. The mortality rate was high in patients with an INR ≥1.5 and <1.5 (with three of the five patients dying) compared to those with an INR <1.5 (0/36 patients died; 30 day mortality 0%). The INR correlated with serious complications (≥Clavien‐Dindo Grade III ), which occurred in all five patients with an INR ≥1.5 and <1.5 vs 12/36 (33%) with an INR <1.5 ( P < 0.002). The median (range) eGFR in those that died was 36 (26–37) mL/min/1.73 m 2 compared to 52 (24–154) mL/min/1.73 m 2 in those that survived ( P = 0.018). Conclusions In patients undergoing combined cardiac and renal tumour surgery raised preoperative INR is associated with a high risk of 30‐day mortality when the patient is elderly (>70 years) and of significant post‐operative complications in younger patients (<70 years). Surgery in patients with a normal INR is challenging but much safer.
No takes yet. Share an insight, caveat, or question.
O’Brien et al. (2016) conducted a cohort in Renal tumours involving the peri-diaphragmatic inferior vena cava and right atrium (n=41). Raised pre-operative INR (≥1.5) vs. Normal pre-operative INR (<1.5) was evaluated on Thirty-day mortality (TDM) (OR +∞, 95% CI 4.04 - +∞, p=0.001). A raised pre-operative INR (≥1.5) was significantly associated with increased thirty-day mortality (60% vs 0%, p=0.001) in patients undergoing simultaneous renal and cardiac surgery.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: